XLXuehui Liu

Xuehui Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuehui Liu has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Wenjuan Wang

    Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Hebei Province Key Laboratory of Environment and Human Health, Shijiazhuang, Hebei, China

    5 shared publications
  • Yi Liu

    Hebei Medical University, Hebei Key Laboratory of Environment and Human Health

    5 shared publications
  • Aibin Qu

    Department of Preventive Medicine, School of Public Health, Hebei Medical University, Shijiazhuang, People’s Republic of China

    4 shared publications
  • Huicai Guo

    Hebei Medical University, Hebei Key Laboratory of Environment and Human Health

    4 shared publications
  • Ran Liu

    Department of Epidemiology and Hygienic Statistics, School of Public Health, Hebei Province Key Laboratory of Environment and Human Health, Hebei Medical University, Shijiazhuang, People’s Republic of China

    4 shared publications
  • Suju Sun

    Department of Epidemiology and Hygienic Statistics, School of Public Health, Hebei Medical University, Hebei Key Laboratory of Environment and Human Health, Shijiazhuang, People’s Republic of China

    4 shared publications

Latest Publications

  • Open Access

    Associations of Plasma Metal Exposure With the Risk and Severity of Acute Coronary Syndrome: Evidence From Epidemiological and Adverse Outcome Pathway Analyses

    by Zeyuan Fu, Zhongxia Hua, Ziyang Huang, Jiaying Song, Liwen Ren, Lixue Yang, Huicai Guo, Yi Liu, Ang Li, Haoran Li, et al.

    Background: Evidence links environmental metal exposure to cardiovascular disease, but its association with acute coronary syndrome (ACS) risk and severity remains insufficiently characterized. Methods: This case–control study included 413 newly diagnosed patients with ACS and 413 controls matched 1:1 by sex and age (within 5 years). Conditional logistic regression assessed associations between individual plasma metals and ACS risk, and ordinal logistic regression evaluated ACS severity. Results: Higher plasma zinc and selenium levels were inversely associated with ACS risk, whereas arsenic and lead showed positive associations. The odds ratios for extreme quantiles were 0.44 (95% CI, 0.22–0.89) for zinc, 0.23 (95% CI, 0.11–0.48) for selenium, 1.70 (95% CI, 0.85–3.41) for arsenic, and 2.46 (95% CI, 1.24–4.87) for lead. Monocyte counts partially mediated the selenium–ACS association, whereas lymphocyte counts mediated the lead–ACS association. Regarding disease severity, selenium was inversely associated with Gensini score (odds ratio, 0.57 [95% CI, 0.32–1.02]) and the number of lesioned vessels (odds ratio, 0.51 [95% CI, 0.28–0.91]), whereas copper was positively associated with the number of lesioned vessels (odds ratio, 1.48 [95% CI, 0.81–2.71]). Bayesian kernel machine regression suggested an inverse association between metal mixtures and ACS risk, with no significant association with severity. Adverse outcome pathway analysis implicated inflammation, oxidative stress, and actin cytoskeleton dysregulation as potential mechanisms. Conclusions: Plasma metal profiles were associated with ACS occurrence and severity, highlighting potential inflammatory, oxidative, and cytoskeletal mechanisms.

  • The association between per-fluoroalkyl and poly-fluoroalkyl substances exposure and thyroid cancer: a meta-analysis

    by Ruyu Wang, Mengze Lv, Siqi Chen, Yueran Zheng, Zeyuan Fu, Xupu Yang, Jingjing Wang, Qianyu Liu, Yi Liu, Xiaolin Zhang, et al.

    Over the last couple of decades, thyroid cancer cases have dramatically increased in frequency year by year. According to certain research, thyroid cancer may be linked to per-fluoroalkyl and poly-fluoroalkyl substances (PFAS) exposure. Our study aimed to investigate the possible link between thyroid cancer and PFAS exposure. Three researchers have looked up the following electronic databases: PubMed, Embase, Web of Science, Scopus, Cochrane, Science Direct, Chinese BioMedical Literature Database (CBM), Wanfang Database, China Science and Technology Journal Database, and China National Knowledge Infrastructure (CNKI) to get the whole articles before March 2024. In addition, Google Scholar was used as a complementary search engine. Finally, eight articles were included in our meta-analysis. It was shown by our results that the link between thyroid cancer and PFAS exposure was not statistically significant, for perfluorononanoic acid (PFNA), odds ratio (OR): 0.71, 95% confidence interval (95% CI): 0.30–1.12; for perfluorooctane sulfonate (PFOS), OR: 0.89, 95% CI: 0.5–1.28; for PFAS mixtures, OR: 1.10, 95% CI: 0.19–2.01. Furthermore, our study revealed that perfluorooctanoic acid (PFOA) exposure could decrease the risk of thyroid cancer (OR: 0.69, 95% CI: 0.44–0.95). These associations of PFOS and PFNA with thyroid cancer were robust in sensitivity analyses. In conclusion, these results increase our knowledge of the impact of PFAS on the thyroid cancer in a novel manner. At the same time, our study has certain limitations, we encourage the inclusion of more high-quality studies in the future.


  • The association between maternal perfluoroalkylated substances exposure and neonatal birth weight: a system review and meta-analysis

    by Zeyuan Fu, Xiaoyi Sun, Xupu Yang, Xiaoqian Li, Yizhe Zhang, Xiaolin Zhang, Huicai Guo, Yi Liu, Xuehui Liu

    Some studies have shown that maternal exposure to perfluoroalkyl substances (PFAS) may be related to the neonatal birth weight. The purpose of this study was to explore this relationship between maternal exposure to PFAS and neonatal birth weight. All papers published before March 2024 were retrieved from the Web of Science, PubMed, and Embase databases. A thorough meta-analysis was carried out, involving data extracted from 1,673 samples obtained from a total of 24 articles. Our study found a significantly negative association between maternal PFOS exposure and neonatal birth weight (β= −71.55; 95 %CI= −114.47, −28.62), with high heterogeneity (I 2 =64.15 %, pβ= −81.26; 95 %CI= −126.08, −36.43), with high heterogeneity (I 2 =67.23 %, pβ= −97.87; 95 %CI= −181.83, −13.92, β= −138.06; 95 %CI= −255.91, −20.20), PFOA exposure showed a negative correlation with neonatal birth weight in mid-to-late pregnancy (β= −85.89; 95 %CI= −139.31, −32.47), while PFNA exposure also showed a negative correlation with neonatal birth weight in mid-to-late pregnancy (β= −90.39; 95 %CI= −152.90, −27.88). However, no significant correlation was observed for PFNA exposure (β=3.95; 95% CI= −10.41, 18.31), with medium heterogeneity (I 2 =40.56 %, p=0.0574), or for PFHxS exposure (β=4.61; 95 %CI= −10.60, 19.81), with medium heterogeneity (I 2 =29.27 %, p=0.1368). Further research is needed to better understand the implications of these findings on maternal and neonatal health.


  • Open Access

    Association between per- and polyfluoroalkyl substances and risk of hypertension: a systematic review and meta-analysis

    by Fang Xiao, Ziwen An, Junli Lv, Xiaoyi Sun, Heming Sun, Yi Liu, Xuehui Liu, Huicai Guo

    Background: Existing evidence indicates that exposure to per- and polyfluoroalkyl substances (PFASs) may increase the risk of hypertension, but the findings are inconsistent. Therefore, we aimed to explore the relationship between PFASs and hypertension through this systematic review and meta-analysis.Methods: We searched PubMed, Embase, and the Web of Science databases for articles published in English that examined the relationship between PFASs and hypertension before 13 August 2022. The random effects model was used to aggregate the evaluation using Stata 15.0 for Windows. We also conducted subgroup analyses by region and hypertension definition. In addition, a sensitivity analysis was carried out to determine the robustness of the findings.Results: The meta-analysis comprised 15 studies in total with 69,949 individuals. The risk of hypertension was substantially and positively correlated with exposure to perfluorooctane sulfonate (PFOS) (OR = 1.31, 95% CI: 1.14, 1.51), perfluorooctanoic acid (PFOA) (OR = 1.16, 95% CI: 1.07, 1.26), and perfluorohexane sulfonate (PFHxS) (OR = 1.04, 95% CI: 1.00, 1.09). However, perfluorononanoic acid (PFNA) exposure and hypertension were not significantly associated (OR = 1.08, 95% CI: 0.99, 1.17).Conclusion: We evaluated the link between PFASs exposure and hypertension and discovered that higher levels of PFOS, PFOA, and PFHxS were correlated with an increased risk of hypertension. However, further high-quality population-based and pathophysiological investigations are required to shed light on the possible mechanism and demonstrate causation because of the considerable variability.Systematic review registration: https://www.crd.york.ac.uk/prospero/ PROSPERO, registration number: CRD 42022358142.


  • Open Access

    Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies

    by Shilin Bd Xue, Wenya Shen, Jianning Cai, Jinhai Jia, Dan Bd Zhao, Shan Bd Zhang, Xiujun Zhao, Ning Ma, Wenjuan Wang, Bingshuang Wang, et al.

    Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail.

  • The relationship between maternal perfluoroalkylated substances exposure and low birth weight of offspring: a systematic review and meta-analysis

    by Tengrui Cao, Aibin Qu, Zixuan Li, Wenjuan Wang, Ran Liu, Xue Wang, Yaxiong Nie, Suju Sun, Xiaolin Zhang, Xuehui Liu

    Some studies have shown that maternal perfluoroalkylated substances (PFAS) exposure may be associated with low birth weight (LBW) of offspring. We conducted a meta-analysis to assess the association between maternal PFASs exposure and LBW in offspring. The researchers searched PubMed, Science Direct, Scopus, Google Scholar, Web of Science, and Embase to find all the articles before October 2020. The Newcastle-Ottawa Scale was used to evaluate the quality of the studies. Finally, six articles were included for meta-analysis. Our meta-analysis showed no significant correlation between maternal perfluorooctanoic acid (PFOA) exposure and LBW of offspring: odds ratio (OR) = 0.90, 95% confidence interval (95% CI) = 0.80–1.01, with low heterogeneity (I2 = 18.4%, P = 0.289); there was a significant positive correlation between maternal perfluorooctane sulfonate (PFOS) exposure and LBW of offspring (OR = 1.32, 95% CI = 1.09–1.55) with no heterogeneity (I2 = 0.00%, P = 0.570). The grouping analysis of PFOS showed was a significant positive correlation between maternal PFOS exposure and LBW of offspring in American (OR = 1.44, 95% CI = 1.15–1.72). This study provided a systematic review and meta-analysis evidence for the relationship between maternal PFASs exposure and LBW of offspring through a small number of studies. Researchers should conduct further studies between different regions.


  • The association between maternal perfluoroalkyl substances exposure and early attention deficit hyperactivity disorder in children: a systematic review and meta-analysis

    by Aibin Qu, Tengrui Cao, Zixuan Li, Wenjuan Wang, Ran Liu, Xue Wang, Yaxiong Nie, Suju Sun, Xuehui Liu, Xiaolin Zhang

    Some studies have shown that maternal exposure to perfluoroalkyl substances (PFASs) may be associated with early attention deficit hyperactivity disorder (ADHD) in children. The purpose of this systematic review and meta-analysis is to verify this association by reviewing existing studies and to provide a strong basis for preventing ADHD. The researchers searched electronic databases such as PubMed, Science Direct, Scopus, Google Scholar, Web of Science, and Embase for all studies published before October 2020. Finally, we included nine articles for analysis. Our meta-analysis showed that maternal exposure to PFASs was not significantly associated with the prevalence rate of early childhood ADHD (perfluorooctanoic acid (PFOA), odds ratio (OR) = 1.00, 95% confidence interval (95% CI) = 0.75–1.25; perfluorooctane sulfonate (PFOS), OR = 1.01, 95% CI = 0.88–1.14; perfluorohexane sulfonate (PFHxS), OR = 1.08, 95% CI = 0.80–1.09; perfluorononanoic acid (PFNA), OR = 1.13, 95% CI = 0.99–1.28; perfluorodecanoic acid (PFDA), OR = 1.23, 95% CI = 0.15–2.32). Due to significant heterogeneity, we subsequently performed subgroup analysis and sensitivity analysis. Through subgroup analysis, we found that PFOS concentration of children’s blood and the prevalence rate of early childhood ADHD were statistically positively correlated, and there was also a positive correlation between PFOS exposure and the prevalence rate of early childhood ADHD in the America. Moreover, there was also a statistically positive correlation between PFNA concentration in maternal blood and the prevalence rate of early childhood ADHD. Sensitivity analysis showed that the final results did not change much, the sensitivity was low, and the results were relatively stable. In conclusion, a causal relationship between maternal PFASs exposure and ADHD in children was unlikely. Among them, PFOS, PFNA, and ADHD might have positive associations worthy of further investigation.


  • Open Access

    The Association Between Maternal Perfluoroalkyl Substances Exposure and Early Attention Deficit Hyperactivity Disorder in Children:A Systematic Review and Meta-Analysis

    by Aibin Qu, Tengrui Cao, Zixuan Li, Wenjuan Wang, Ran Liu, Xue Wang, Yaxiong Nie, Suju Sun, Xuehui Liu, Xiaolin Zhang

    Some studies have shown that maternal exposure to perfluoroalkyl substances (PFASs) may be associated with early attention deficit hyperactivity disorder (ADHD) in children. The purpose of this systematic review and meta-analysis is to verify this association by reviewing existing studies and to provide a strong basis for preventing ADHD. The researchers searched electronic databases such as PubMed, Science Direct, Scopus, Google Scholar, Web of Science, and Embase for all studies published before October 2020. Finally, we included nine articles for analysis. Our meta-analysis showed that maternal exposure to PFASs was not significantly associated with the prevalence rate of early childhood ADHD (perfluorooctanoic acid (PFOA): odds ratio (OR) = 1.00, 95% confidence interval (95% CI) = 0.75–1.25; perfluorooctane sulfonate (PFOS): OR = 1.01, 95% CI = 0.88–1.14; perfluorohexane sulfonate (PFHxS): OR = 1.08, 95% CI = 0.80–1.09; perfluorononanoic acid (PFNA): OR = 1.13, 95% CI = 0.99–1.28; perfluorodecanoic acid (PFDA): OR = 1.23, 95% CI = 0.15–2.32). Due to significant heterogeneity, we subsequently performed subgroup analysis and sensitivity analysis. In conclusion, a causal relationship between maternal PFASs exposure and ADHD in children was unlikely. Among them, PFOS, PFNA and ADHD might have positive associations worthy of further investigation.


  • Open Access

    The relationship between maternal perfluoroalkylated substances exposure and low birth weight of offspring: A systematic review and meta-analysis

    by Tengrui Cao, Aibin Qu, Zixuan Li, Wenjuan Wang, Ran Liu, Xue Wang, Yaxiong Nie, Suju Sun, Xiaolin Zhang, Xuehui Liu

    Some studies have shown that maternal perfluoroalkylated substances (PFAS) exposure may be associated with low birth weight (LBW) of offspring. We conducted a meta-analysis to assess the association between maternal PFASs exposure and LBW in offspring. The researchers searched PubMed, Science Direct, Scopus, Google Scholar, Web of Science, and Embase to find all the articles before October 2020. The Newcastle-Ottawa Scale was used to evaluate the quality of the studies. Finally, six articles were included for meta-analysis. Our meta-analysis showed were no significant correlation between maternal perfluorooctanoic acid (PFOA) exposure and LBW of offspring: odds ratio (OR) = 0.90, 95% confidence interval (95% CI) = 0.80–1.01, with low heterogeneity (I2 = 18.4%, P = 0.289); there was a significant positive correlation between maternal perfluorooctane sulfonate (PFOS) exposure and LBW of offspring (OR = 1.32, 95% CI = 1.09–1.55) with no heterogeneity (I2 = 0.00%, P = 0.570). The grouping analysis of PFOS showed was a significant positive correlation between maternal PFOS exposure and LBW of offspring in America (OR = 1.44, 95% CI = 1.15–1.72). This study provided a systematic review and meta-analysis evidence for the relationship between maternal PFASs exposure and LBW of offspring through a small number of studies. Researchers should conduct further studies between different regions.